Iridex (IRIX) CFO Reports 1,005-Share Open-Market Purchases
Rhea-AI Filing Summary
Romeo R. Dizon, Chief Financial Officer of Iridex Corp (IRIX), reported multiple open-market purchases totaling 1,005 shares on 08/28/2025. The transactions executed at prices between $1.325 and $1.36 per share increased his direct beneficial ownership from 50,745 shares to 51,750 shares. Individual purchases reported: 50 shares at $1.33, 200 shares at $1.325, 250 shares at $1.35 and 505 shares at $1.36. The Form 4 was signed by an attorney-in-fact on 08/29/2025. No derivative transactions were reported and no additional explanatory text was provided.
Positive
- CFO increased direct ownership by 1,005 shares, rising to 51,750 shares, which aligns management interest with shareholders
- Transparent disclosure: Form 4 reports transaction dates, share counts, and prices, and is properly signed
Negative
- None.
Insights
TL;DR: Insider purchases totaling 1,005 shares at low single-digit dollar prices modestly increased CFO ownership; routine disclosure, limited market impact.
These are straightforward, small open-market acquisitions by the company's CFO reported on Form 4. The total outlay (~$1,350) is immaterial relative to typical market-cap metrics and does not indicate a major change in control or financing. For investors, the filing primarily documents insider accumulation but is unlikely to move valuation metrics or signal a material change in corporate strategy given the size.
TL;DR: Properly filed Form 4 documenting direct purchases by an officer; no governance red flags present in the disclosure.
The Form 4 lists the reporting person, relationship (CFO), transaction dates, codes, share counts, and prices, and is signed by an attorney-in-fact. There are no amendments, derivative transactions, or indications of Rule 10b5-1 plans checked. From a governance perspective, the filing meets disclosure requirements and raises no immediate compliance concerns.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 50 | $1.33 | $66.50 |
| Purchase | Common Stock | 200 | $1.325 | $265.00 |
| Purchase | Common Stock | 250 | $1.35 | $337.50 |
| Purchase | Common Stock | 505 | $1.36 | $686.80 |
Footnotes (1)
FAQ
What trades did IRIX CFO Romeo R. Dizon report on Form 4?
Were any derivative securities (options, warrants, etc.) reported for IRIX in this filing?
When were the transactions and who signed the Form 4?
Do these purchases indicate a material change in control or strategy at IRIX?